4//SEC Filing
Wisler Gerald 4
Accession 0001179110-13-006930
CIK 0001477598other
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 8:58 PM ET
Size
20.0 KB
Accession
0001179110-13-006930
Insider Transaction Report
Form 4
Wisler Gerald
DirectorPresident and CEO
Transactions
- Conversion
Common Stock
2013-04-16+36,574→ 645,761 total - Conversion
Common Stock
2013-04-16$8.00/sh+12,664$101,312→ 661,546 total - Conversion
Warrant (right to buy)
2013-04-16−3,125→ 0 totalExercise: $0.01From: 2013-04-16Exp: 2023-02-15→ Common Stock (3,125 underlying) - Conversion
Common Stock
2013-04-16$0.01/sh+3,125$31→ 648,886 total - Conversion
Series B Convertible Preferred Stock
2013-04-16−51,033→ 0 total→ Common Stock (36,574 underlying) - Conversion
Secured Convertible Promissory Note
2013-04-16−12,664→ 0 totalExercise: $8.00From: 2013-04-16Exp: 2014-02-15→ Common Stock (12,664 underlying) - Sale
Common Stock
2013-04-16$8.00/sh−4$32→ 648,882 total
Holdings
- 331,963(indirect: By Trust)
Common Stock
- 331,963(indirect: By Trust)
Common Stock
- 26,382(indirect: By Trust)
Common Stock
- 26,382(indirect: By Trust)
Common Stock
Footnotes (8)
- [F1]Represents the total number of shares received upon conversion of shares of the Issuer's Series B Convertible Preferred Stock (the "Series B Shares").
- [F2]Represents the total number of shares received upon conversion of the reporting person's warrant.
- [F3]Effective upon the closing of the Issuer's initial public offering ("IPO") of its Common Stock, the reporting person's warrant automatically converted into 3,125 shares of Common Stock. The reporting person paid the exercise price of $0.01 per share of the warrant on a cashless basis, resulting in the Issuer's withholding of 4 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 3,121 shares.
- [F4]Represents the total number of shares received upon conversion of the Secured Convertible Promissory Note issued to the reporting person.
- [F5]These shares are held in a trust for the benefit of one of the reporting person's children. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, except to the extent of the reporting person's pecuniary interest, if any, therein, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F6]Effective upon the closing of the Issuer's IPO of its Common Stock, each Series B Share automatically converted at a ratio of 1.3953-to-1 into the number of shares of Common Stock shown in column 7. The Series B Shares had no expiration date.
- [F7]This is the maturity date of the Secured Convertible Promissory Note.
- [F8]The Secured Convertible Promissory Note was issued to the reporting person in exchange for $100,000. Effective upon the closing of the Issuer's IPO of its Common Stock, the Secured Convertible Promissory Note automatically converted into the number of shares of Common Stock shown in column 7.
Documents
Issuer
Omthera Pharmaceuticals, Inc.
CIK 0001477598
Entity typeother
Related Parties
1- filerCIK 0001402054
Filing Metadata
- Form type
- 4
- Filed
- Apr 16, 8:00 PM ET
- Accepted
- Apr 17, 8:58 PM ET
- Size
- 20.0 KB